ALLO Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $1.50

Piyasa Değeri (MRQ) $518M

P/E -1.8

Hisse Başına Kâr $-0.87

Gelir $0

ROE -59.9%

52 Haftlık Aralık $1–$4

ALLO Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Gelir$0

2022-12-31 → 2025-12-31

Hisse Başına Kâr$-0.87

2022-12-31 → 2025-12-31

Serbest Nakit Akışı$-150M

2023-12-31 → 2025-12-31

Net kar marjı·

2023-12-31 → 2024-12-31

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	ALLO	5Y ort.	Akran Ortalaması	Sonuç
P/E	-1.85Y ort. ≈-1.6	≈-1.6	·	·
F/D (MRQ)	1.25Y ort. ≈1.1	≈1.1	4.7	Düşük değerli
Fiyat / Serbest Nakit Akışı (TTM)	-5.05Y ort. ≈-2.2	≈-2.2	·	·
Fiyat / Nakit Akışı (TTM)	-5.15Y ort. ≈-2.2	≈-2.2	·	·
Price / Tangible Book (Fiyat / Maddi Defter Değeri)	1.35Y ort. ≈1.1	≈1.1	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	ALLO	5Y ort.	Akran Ortalaması	Sonuç
ROA	-39.6%5Y ort. ≈-43.7%	≈-43.7%	-39.6%	Aynı seviyede
ROE	-59.9%5Y ort. ≈-59.3%	≈-59.3%	-45.6%	Zayıf
ROIC	-71.5%	·	-35.8%	Zayıf

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	5 Yıllık trend	ALLO	5Y ort.	Akran Ortalaması	Sonuç
Cari Oran (MRQ)		10.75Y ort. ≈9.6	≈9.6	11.8	Aynı seviyede
Quick Ratio (Cari Oran)		1.65Y ort. ≈2.0	≈2.0	11.5	Düşük likidite

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik	5 Yıllık trend	ALLO	5Y ort.	Akran Ortalaması	Sonuç
Revenue YoY (Gelir Yıllık Bazda)		-76.8%	·	·	·
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)		-94.2%	·	·	·

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	ALLO	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$-0.875Y ort. ≈$-1.43	≈$-1.43	·	·
Revenue / Share (Hisse Başına Gelir)	$0.005Y ort. ≈$0.00	≈$0.00	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$-0.685Y ort. ≈$-1.07	≈$-1.07	·	·
Cash / Share (Hisse Başına Nakit)	$0.235Y ort. ≈$0.36	≈$0.36	·	·

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik	5 Yıllık trend	ALLO	5Y ort.	Akran Ortalaması	Sonuç
Asset Turnover (Aktif Devir Hızı)		0.05Y ort. ≈0.0	≈0.0	0.0	Zayıf
Revenue / Employee (Çalışan Başına Gelir)		≈$0.00	·	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz 15.9%

Sonraki Rapor Kas 04, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Ağu 12, 2026	$-0.13	$-0.17	25.5%
31 Mart 2026	May 13, 2026	$-0.18	$-0.19	7.3%
31 Aralık 2025		$-0.17	$-0.22	23.0%
30 Eylül 2025		$-0.19	$-0.23	16.6%
30 Haziran 2025		$-0.23	$-0.28	17.6%
31 Mart 2025		$-0.28	$-0.30	5.2%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 15

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue	$0	$22.0K	$95.0K	$156.0K	$114M	$0	$0
R&D Expense	$150M	$192M	$243M	$256M	$220M	$193M	$145M
SG&A Expense	$57M	$65M	$72M	$79M	$74M	$65M	$57M
Operating Expenses	$209M	$273M	$328M	$336M	$294M	$258M	$202M
Operating Income	$-209M	$-273M	$-328M	$-336M	$-180M	$-258M	$-202M
Interest Expense	·	·	·	·	·	$0	$0
Other Non-op	$215.0K	$-4M	$-18M	$-9M	$-4M	$-67M	$17M
Pretax Income	$-191M	$-257M	$-327M	·	$-257M	$-250M	$-185M
Income Tax	$0	$443.0K	$0	$0	$0	$0	$-331.0K
Net Income	$-191M	$-258M	$-327M	$-340M	$-182M	$-316M	$-185M
EPS (Basic)	$-0.87	$-1.32	$-2.09	$-2.38	$-1.34	$-2.63	$-1.83
EPS (Diluted)	$-0.87	$-1.32	$-2.09	$-2.38	$-1.34	$-2.63	$-1.83
Shares (Basic)	220,622,669	194,811,756	156,931,778	143,147,165	135,820,386	120,370,177	101,061,149
Shares (Diluted)	220,622,669	194,811,756	156,931,778	143,147,165	135,820,386	120,370,177	101,061,149
EBITDA	$-197M	$-260M	$-314M	·	$-245M	$-251M	$-197M

Bilanço 21

Metrik	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$52M	$75M	$83M	$62M	$173M	$183M	$175M
Short-term Investments	·	·	·	·	$284M	$645M	$355M
Prepaid Expense	$8M	$11M	$10M	$12M	$14M	$17M	$14M
Current Assets	$258M	$303M	$459M	$529M	$471M	$845M	$545M
PP&E (Net)	$73M	$86M	$99M	$113M	$123M	$119M	$56M
PP&E (Gross)	$145M	$149M	$151M	$150M	$146M	$132M	$62M
Accum. Depreciation	$73M	$63M	$51M	$37M	$23M	$13M	$5M
Intangibles	·	·	·	·	·	$0	$151.0K
Other Non-current Assets	$4M	$2M	$7M	$10M	$6M	$5M	$5M
Total Assets	$416M	$549M	$643M	$822M	$1.05B	$1.23B	$718M
Accounts Payable	$4M	$5M	$6M	$14M	$10M	$10M	$9M
Current Liabilities	$33M	$36M	$37M	$54M	$48M	$94M	$33M
Capital Leases	$75M	$83M	$88M	$95M	$70M	$51M	$51M
Other Non-current Liabilities	$16M	$8M	$5M	$6M	$8M	$3M	$4M
Total Liabilities	$123M	$127M	$131M	$155M	$126M	$148M	$89M
Common Stock	$229.0K	$212.0K	$169.0K	$144.0K	$142.0K	$140.0K	$124.0K
Retained Earnings	$-2.01B	$-1.82B	$-1.56B	$-1.23B	$-895M	$-713M	$-396M
AOCI	$269.0K	$-89.0K	$-955.0K	$-10M	$-3M	$268.0K	$1M
Stockholders' Equity	$293M	$422M	$512M	$667M	$925M	$1.01B	$629M
Liabilities + Equity	$416M	$549M	$643M	$822M	$1.05B	$1.23B	$718M
Shares Outstanding	229,413,523	212,210,597	168,642,238	144,438,304	142,623,065	140,474,305	124,267,358

Nakit Akışı 15

Metrik	2025	2024	2023	2022	2021	2020	2019
D&A	$12M	$14M	$14M	$14M	$10M	$7M	$5M
Stock-based Comp	$38M	$52M	$66M	$84M	$81M	$65M	$46M
Deferred Tax	$0	$443.0K	$0	·	·	·	·
Amort. of Intangibles	·	·	·	$0	$0	$151.0K	$603.0K
Restructuring	$5M	·	·	·	·	·	·
Other Non-cash	$-8M	$-9M	$9M	·	$-19M	$62M	$-3M
Operating Cash Flow	$-149M	$-200M	$-238M	$-221M	$-185M	$-115M	$-137M
CapEx	$386.0K	$694.0K	$2M	$5M	$21M	$66M	$51M
Investing Cash Flow	$96M	$76M	$163M	$106M	$164M	$-505M	$164M
Stock Issued	·	·	$91M	$0	$0	$596M	$0
Net Stock Activity	·	·	$91M	·	$0	$622M	$54M
Financing Cash Flow	$30M	$117M	$96M	$3M	$12M	$634M	$59M
Net Change in Cash	$-24M	$-8M	$21M	$-111M	$-9M	$13M	$86M
Free Cash Flow	$-150M	$-201M	$-239M	·	$-206M	$-181M	$-188M
Levered FCF	·	·	·	·	·	$-181M	$-188M

Kârlılık 7

Metrik	2025	2024	2023	2022	2021	2020	2019
Operating Margin	·	-1241813.6%	-344986.3%	·	-664.6%	·	·
Net Margin	·	-1170863.6%	-344489.5%	·	-667.7%	·	·
Pretax Margin	·	-1168850.0%	·	·	-667.7%	·	·
EBITDA Margin	·	-1179818.2%	-330039.0%	·	-637.3%	·	·
ROA	-39.6%	-43.2%	-48.3%	·	-22.7%	-25.7%	-24.8%
ROE	-59.9%	-58.1%	-59.9%	·	-27.3%	-22.8%	-29.6%
ROIC	-71.5%	-64.8%	·	·	-27.9%	-23.9%	-32.1%

Likidite ve Solventlik 2

Metrik	Eğilim	2025	2024	2023	2022	2021	2020	2019
Current Ratio		7.9	8.5	12.4	·	9.8	9.0	16.5
Quick Ratio		1.6	2.1	2.2	·	9.5	8.8	16.0

Verimlilik 1

Metrik	Eğilim	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		0.0	0.0	0.0	·	0.0	·	·

Hisse Başına 6

Metrik	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$1.28	$1.99	$3.04	·	$6.43	$7.69	$5.06
Revenue / Share	$0.00	$0.00	$0.00	·	$0.28	·	·
Cash Flow / Share	$-0.68	$-1.03	$-1.51	·	$-1.36	·	·
Cash / Share	$0.23	$0.35	$0.49	·	$1.22	$1.31	$1.41
Dividend / Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
EPS (TTM)	$-0.87	$-1.32	$-2.09	$-2.38	$-1.34	$-2.63	$-1.83

Büyüme Oranları 2

Metrik	Eğilim	2025	2024	2023	2022	2021	2020	2019
Revenue YoY		·	-76.8%	-39.1%	-99.9%	·	·	·
Revenue CAGR 3Y		·	-94.2%	·	·	·	·	·

Değerleme (TTM) 10

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$0	$22.0K	$95.0K	$156.0K	$114M	$0	$0
Net Income TTM	$-191M	$-258M	$-327M	$-340M	$-182M	$-316M	$-185M
Market Cap	$314M	$452M	$541M	·	$2.13B	$3.55B	$3.23B
P/E	-1.6	-1.6	-1.5	-2.6	-11.1	-9.6	-14.2
P/S	·	20545.8	5698.3	·	18.7	·	·
P/B	1.1	1.1	1.1	·	2.3	3.3	5.1
P / Tangible Book	1.1	1.1	1.1	1.4	2.3	3.5	·
P / Cash Flow	-2.1	-2.3	-2.3	·	-11.5	-30.8	-23.5
P / FCF	-2.1	-2.2	-2.3	·	-10.3	-19.6	-17.2
Earnings Yield	-63.5%	-62.0%	-65.1%	-37.8%	-9.0%	-10.4%	-7.0%

Gelir Tablosu 12

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$5M	·	$0	$0	$0	$0	$0	$0	$0	$22.0K	$21.0K	$22.0K	$22.0K	$30.0K	$-40.0K	$27.0K
R&D Expense	$31M	$32M	$29M	$31M	$40M	$50M	$45M	$45M	$50M	$52M	$55M	$46M	$62M	$80M	$75M	$64M
SG&A Expense	$21M	$14M	$14M	$14M	$14M	$15M	$16M	$16M	$16M	$17M	$17M	$17M	$19M	$19M	$21M	$19M
Operating Expenses	$52M	$46M	$42M	$45M	$57M	$65M	$60M	$72M	$71M	$70M	$85M	$63M	$81M	$99M	$96M	$83M
Operating Income	$-47M	$-46M	$-42M	$-45M	$-57M	$-65M	$-60M	$-72M	$-71M	$-70M	$-85M	$-63M	$-81M	$-99M	$-96M	$-83M
Other Non-op	$-61.0K	$212.0K	$247.0K	$-81.0K	$-43.0K	$92.0K	$-2M	$-1M	$85.0K	$-929.0K	$-12M	$-5M	$-2M	$2M	$-10M	$-3M
Net Income	$-43M	$-43M	$-39M	$-41M	$-51M	$-60M	$-60M	$-66M	$-66M	$-65M	$-86M	$-62M	$-79M	$-100M	$-103M	$-84M
EPS (Basic)	$-0.13	$-0.18	$-0.17	$-0.19	$-0.23	$-0.28	$-0.27	$-0.32	$-0.35	$-0.38	$-0.49	$-0.37	$-0.54	$-0.69	$-0.72	$-0.59
EPS (Diluted)	$-0.13	$-0.18	$-0.17	$-0.19	$-0.23	$-0.28	$-0.27	$-0.32	$-0.35	$-0.38	$-0.49	$-0.37	$-0.54	$-0.69	$-0.72	$-0.59
Shares (Basic)	328,930,269	240,290,782	·	222,038,680	218,929,548	215,358,619	·	209,188,551	190,026,638	169,128,362	·	167,649,010	146,795,826	144,563,829	·	143,661,721
Shares (Diluted)	328,930,269	240,290,782	·	222,038,680	218,929,548	215,358,619	·	209,188,551	190,026,638	169,128,362	·	167,649,010	146,795,826	144,563,829	·	143,661,721
EBITDA	$-47M	$-43M	·	$-45M	$-57M	$-62M	·	$-72M	$-71M	$-70M	·	$-63M	$-81M	$-99M	·	$-82M

Bilanço 19

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$39M	$30M	$52M	$38M	$52M	$42M	$75M	$51M	$171M	$51M	$83M	$69M	$155M	$110M	$62M	$74M
Prepaid Expense	$7M	$6M	$8M	$9M	$10M	$12M	$11M	$13M	$12M	$11M	$10M	$8M	$10M	$10M	$12M	$17M
Current Assets	$340M	$273M	$258M	$261M	$283M	$292M	$303M	$304M	$457M	$395M	$459M	$473M	$502M	$481M	$529M	$569M
PP&E (Net)	$67M	$70M	$73M	$76M	$79M	$83M	$86M	$89M	$92M	$96M	$99M	$103M	$106M	$110M	$113M	$114M
PP&E (Gross)	$145M	$145M	$145M	$145M	$146M	$149M	$149M	$149M	$148M	$151M	$151M	$150M	$150M	$150M	$150M	$149M
Accum. Depreciation	$78M	$75M	$73M	$70M	$67M	$66M	$63M	$60M	$56M	$55M	$51M	$48M	$44M	$40M	$37M	$35M
Other Non-current Assets	$4M	$4M	$4M	$4M	$4M	$2M	$2M	$5M	$6M	$5M	$7M	$10M	$9M	$9M	$10M	$9M
Total Assets	$550M	$396M	$416M	$440M	$471M	$508M	$549M	$589M	$647M	$586M	$643M	$712M	$771M	$747M	$822M	$888M
Accounts Payable	$6M	$5M	$4M	$4M	$5M	$5M	$5M	$6M	$13M	$6M	$6M	$6M	$10M	$15M	$14M	$11M
Current Liabilities	$32M	$28M	$33M	$32M	$32M	$30M	$36M	$33M	$37M	$31M	$37M	$38M	$55M	$60M	$54M	$49M
Capital Leases	$70M	$73M	$75M	$77M	$79M	$81M	$83M	$85M	$87M	$89M	$88M	$90M	$92M	$94M	$95M	$97M
Other Non-current Liabilities	$12M	$16M	$16M	$15M	$15M	$11M	$8M	$8M	$8M	$5M	$5M	$1M	$2M	$2M	$6M	$2M
Total Liabilities	$114M	$117M	$123M	$124M	$126M	$123M	$127M	$125M	$132M	$125M	$131M	$129M	$148M	$155M	$155M	$148M
Common Stock	$345.0K	$245.0K	$229.0K	$223.0K	$220.0K	$219.0K	$212.0K	$210.0K	$209.0K	$170.0K	$169.0K	$168.0K	$167.0K	$146.0K	$144.0K	$144.0K
Retained Earnings	$-2.10B	$-2.05B	$-2.01B	$-1.97B	$-1.93B	$-1.88B	$-1.82B	$-1.76B	$-1.69B	$-1.63B	$-1.56B	$-1.47B	$-1.41B	$-1.33B	$-1.23B	$-1.14B
AOCI	$-518.0K	$-183.0K	$269.0K	$235.0K	$-45.0K	$43.0K	$-89.0K	$157.0K	$-780.0K	$-927.0K	$-955.0K	$-2M	$-4M	$-6M	$-10M	$-13M
Stockholders' Equity	$436M	$279M	$293M	$315M	$345M	$385M	$422M	$464M	$515M	$461M	$512M	$583M	$623M	$592M	$667M	$740M
Liabilities + Equity	$550M	$396M	$416M	$440M	$471M	$508M	$549M	$589M	$647M	$586M	$643M	$712M	$771M	$747M	$822M	$888M
Shares Outstanding	345,345,427	244,816,413	229,413,523	223,163,672	220,133,876	218,598,262	212,210,597	209,500,137	209,049,485	170,452,967	168,642,238	168,175,221	167,133,664	145,740,333	144,438,304	144,031,588

Nakit Akışı 12

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$4M	$4M	$3M	$4M	·	·	·	·
Stock-based Comp	$12M	$8M	$8M	$9M	$9M	$12M	$13M	$13M	$14M	$12M	$15M	$15M	$17M	$19M	$17M	$21M
Restructuring	·	·	$0	$0	·	·	·	·	·	·	·	·	·	·	·	·
Other Non-cash	·	$19M	·	·	·	$-8M	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-32M	$-13M	$-28M	$-30M	$-39M	$-53M	$-37M	$-44M	$-64M	$-56M	$-54M	$-56M	$-62M	$-67M	$-62M	$-48M
CapEx	$150.0K	$9.0K	$0	$243.0K	$44.0K	$99.0K	$257.0K	$429.0K	$0	$8.0K	$181.0K	$12.0K	$288.0K	$1M	$2M	$223.0K
Investing Cash Flow	$-148M	$-30M	$34M	$12M	$44M	$6M	$55M	$-76M	$75M	$22M	$67M	$-34M	$17M	$113M	$50M	$25M
Stock Issued	·	·	·	·	·	$10M	·	·	·	$0	·	$3M	·	·	$0	$0
Net Stock Activity	·	·	·	·	·	$10M	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$188M	$21M	$8M	$3M	$5M	$14M	$6M	$679.0K	$109M	$2M	$155.0K	$4M	$90M	$2M	$46.0K	$1M
Net Change in Cash	$8M	$-21M	$14M	$-15M	$10M	$-33M	$24M	$-119M	$120M	$-32M	$14M	$-86M	$45M	$48M	$-12M	$-22M
Free Cash Flow	·	$-13M	·	·	·	$-53M	·	·	·	$-56M	·	·	·	$-68M	·	·

Kârlılık 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-1011.2%	·	·	·	·	·	·	·	·	-315927.3%	·	-146453.5%	-182995.5%	-190519.2%	·	-168344.9%
Net Margin	-919.8%	·	·	·	·	·	·	·	·	-295454.6%	·	-142593.0%	-177247.7%	-189815.4%	·	-169689.8%
EBITDA Margin	-1011.2%	·	·	·	·	·	·	·	·	-315927.3%	·	-146453.5%	-182995.5%	-190519.2%	·	-168344.9%
ROA	-8.4%	-9.4%	·	-8.1%	-9.1%	-10.9%	·	-10.2%	-9.4%	-9.8%	·	-7.7%	-9.1%	-11.5%	·	-8.5%
ROE	-10.9%	-12.8%	·	-10.6%	-11.8%	-14.1%	·	-12.7%	-11.7%	-12.3%	·	-9.3%	-10.9%	-13.6%	·	-9.7%

Likidite ve Solventlik 2

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		10.7	9.6	·	8.2	8.9	9.7	·	9.3	12.3	12.8	·	12.6	9.2	8.1	·	11.6
Quick Ratio		1.2	1.1	·	1.2	1.7	1.4	·	1.6	4.6	1.7	·	1.8	2.8	1.8	·	1.5

Verimlilik 1

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	·	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0

Hisse Başına 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$1.26	$1.14	·	$1.41	$1.57	$1.76	·	$2.21	$2.46	$2.71	·	$3.47	$3.73	$4.06	·	$5.14
Revenue / Share	$0.01	·	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00
Cash Flow / Share	·	$-0.05	·	·	·	$-0.25	·	·	·	$-0.33	·	·	·	$-0.46	·	·
Cash / Share	$0.11	$0.12	·	$0.17	$0.24	$0.19	·	$0.24	$0.82	$0.30	·	$0.41	$0.93	$0.75	·	$0.52
EPS (TTM)	$-0.67	$-0.77	·	$-0.97	$-1.10	$-1.22	·	$-1.54	$-1.59	$-1.78	·	$-2.32	$-2.54	$-2.56	·	$-1.70

Değerleme (TTM) 9

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	·	$0	·	$0	$0	$0	·	$43.0K	$65.0K	$87.0K	·	$34.0K	$39.0K	$81.0K	·	$76M
Net Income TTM	$-165M	$-174M	·	$-212M	$-237M	$-252M	·	$-283M	$-279M	$-292M	·	$-344M	$-366M	$-367M	·	$-243M
Market Cap	$718M	$597M	·	$277M	$249M	$319M	·	$587M	$487M	$762M	·	$533M	$831M	$720M	·	$1.56B
P/E	-3.1	-3.2	·	-1.3	-1.0	-1.2	·	-1.8	-1.5	-2.5	·	-1.4	-2.0	-1.9	·	-6.4
P/S	·	·	·	·	·	·	·	13641.9	7493.6	8757.8	·	15679.9	21298.8	8888.4	·	20.5
P/B	1.6	2.1	·	0.9	0.7	0.8	·	1.3	0.9	1.7	·	0.9	1.3	1.2	·	2.1
P / Tangible Book	1.6	2.1	·	0.9	0.7	0.8	·	1.3	0.9	1.7	·	0.9	1.3	1.2	·	2.1
P / Cash Flow	·	-46.3	·	·	·	-6.0	·	·	·	-13.6	·	·	·	-10.8	·	·
Earnings Yield	-32.2%	-31.6%	·	-78.2%	-97.4%	-83.6%	·	-55.0%	-68.2%	-39.8%	·	-73.2%	-51.1%	-51.8%	·	-15.7%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2023-09-30	2023-06-30
Gelir	$0	$22.0K	$95.0K	·	·
Faaliyet Kâr Marjı %	·	-1241813.6%	-344986.3%	·	·
Net Gelir	$-191M	$-258M	$-327M	·	·
Seyreltilmiş Hisse Başı Kâr	$-0.87	$-1.32	$-2.09	·	·

Metrik	2025-12-31	2024-12-31	2023-12-31	2023-09-30	2023-06-30
Cari Oran	7.9	8.5	12.4	·	·
Cari Oran	1.6	2.1	2.2	·	·

Metrik	2025-12-31	2024-12-31	2023-12-31	2023-09-30	2023-06-30
Serbest Nakit Akışı	$-150M	$-201M	$-239M	·	·

Kurumsal Sahipler (13F) 228 dosya · $652.3M toplam · Tarih itibarıyla 30 Haziran 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 228

Tutulan Değer $652.3M

Yeni pozisyonlar 34

Çıkan pozisyonlar 27

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
34 (-18 önceki Ç'ye göre)	27 (+16 önceki Ç'ye göre)	100 (+19 önceki Ç'ye göre)	51 (+10 önceki Ç'ye göre)	+129.2M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
BlackRock, Inc.	$62.705.681	30.146.963	9,61%	Hisse senetleri
Pfizer Inc	$46.928.245	22.032.040	7,19%	Hisse senetleri
Frazier Life Sciences Management, L.P.	$46.689.069	22.446.668	7,16%	Hisse senetleri
STATE STREET CORP	$39.573.718	19.025.826	6,07%	Hisse senetleri
TPG GP A, LLC	$38.929.916	18.716.306	5,97%	Hisse senetleri
Sio Capital Management, LLC	$27.712.736	13.323.431	4,25%	Hisse senetleri
PRIMECAP MANAGEMENT CO/CA/	$27.296.756	13.123.440	4,18%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$25.306.603	12.166.636	3,88%	Hisse senetleri
FMR LLC	$24.978.809	12.009.043	3,83%	Hisse senetleri
CITADEL ADVISORS LLC	$20.982.562	10.087.770	3,22%	Hisse senetleri
TWO SIGMA INVESTMENTS, LP	$16.191.444	7.784.348	2,48%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$14.666.040	7.049.328	2,25%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$12.789.834	6.148.959	1,96%	Hisse senetleri
VANGUARD GROUP INC	$12.674.704	9.251.609	1,94%	Hisse senetleri
GordonMD Global Investments LP	$11.019.840	5.298.000	1,69%	Hisse senetleri
MARSHALL WACE, LLP	$10.598.449	5.095.408	1,62%	Hisse senetleri
Patient Square Capital LP	$10.504.000	5.050.000	1,61%	Hisse senetleri
Aberdeen Group plc	$10.403.644	5.001.752	1,60%	Hisse senetleri
MILLENNIUM MANAGEMENT LLC	$10.075.289	4.843.889	1,54%	Hisse senetleri
D. E. Shaw & Co., Inc.	$9.798.329	4.710.735	1,50%	Hisse senetleri
MORGAN STANLEY	$9.380.720	4.509.962	1,44%	Hisse senetleri
Woodline Partners LP	$9.361.298	4.500.624	1,44%	Hisse senetleri
Candriam S.C.A.	$9.010.818	4.336.296	1,38%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$8.761.122	4.212.078	1,34%	Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC	$7.975.369	3.834.312	1,22%	Hisse senetleri
Walleye Capital LLC	$6.797.465	3.268.012	1,04%	Hisse senetleri
RTW INVESTMENTS, LP	$6.760.000	3.250.000	1,04%	Hisse senetleri
DIMENSIONAL FUND ADVISORS LP	$6.740.207	3.239.077	1,03%	Hisse senetleri
BANK OF AMERICA CORP /DE/	$6.629.626	3.187.320	1,02%	Hisse senetleri
UBS Group AG	$6.319.855	3.038.392	0,97%	Hisse senetleri
Ghisallo Capital Management LLC	$6.240.000	3.000.000	0,96%	Hisse senetleri
NORTHERN TRUST CORP	$6.146.986	2.955.282	0,94%	Hisse senetleri
Wildcat Capital Management, LLC	$6.075.237	2.920.787	0,93%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$4.730.675	2.274.363	0,73%	Hisse senetleri
AQR CAPITAL MANAGEMENT LLC	$4.173.079	2.006.288	0,64%	Hisse senetleri
DAFNA Capital Management LLC	$4.160.000	2.000.000	0,64%	Hisse senetleri
TWO SIGMA ADVISERS, LP	$3.959.574	2.890.200	0,61%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$3.823.756	1.838.344	0,59%	Hisse senetleri
JPMORGAN CHASE & CO	$3.193.323	1.438.434	0,49%	Hisse senetleri
Boxer Capital Management, LLC	$3.120.000	1.500.000	0,48%	Hisse senetleri
JACOBS LEVY EQUITY MANAGEMENT, INC	$3.026.614	1.455.103	0,46%	Hisse senetleri
Raiffeisen Bank International AG	$2.442.000	1.100.000	0,37%	Hisse senetleri
Vida Ventures Advisors, LLC	$2.229.722	1.798.163	0,34%	Hisse senetleri
Invesco Ltd.	$1.607.395	772.786	0,25%	Hisse senetleri
Bank of New York Mellon Corp	$1.512.540	727.182	0,23%	Hisse senetleri
Man Group plc	$1.459.954	701.901	0,22%	Hisse senetleri
RAYMOND JAMES FINANCIAL INC	$1.412.262	678.972	0,22%	Hisse senetleri
Nuveen, LLC	$1.299.268	624.648	0,20%	Hisse senetleri
IEQ CAPITAL, LLC	$1.207.172	580.371	0,19%	Hisse senetleri
Mitsubishi UFJ Asset Management Co., Ltd.	$1.138.153	547.189	0,17%	Hisse senetleri

Tüm 228 kurumsal sahibi göster →

Aktivistler ve %5+ sahipler 6 pozisyon

18

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi	Dosyalandı	Hisse	Durum	Amaç	Başvuru
James G. Coulter, Jon Winkelried, TPG GP A, LLC	30 Eylül 2026	0,00%	Değişiklik	·	SEC
Pfizer Inc.	13 Şubat 2026	9,00%	Değişiklik	·	SEC
Pfizer Inc. (“Pfizer”) ×3 başvurular	25 Ekim 2023	·	İlk başvuru	·	SEC
TPG GP A, LLC, David Bonderman, James G. Coulter, Jon Winkelried	18 Ocak 2022	·	İlk başvuru	·	SEC
TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter ×4 başvurular	10 Ağustos 2020	·	İlk başvuru	·	SEC
Pfizer Inc. (“ Pfizer ”)	22 Ekim 2018	·	İlk başvuru	Pasif yatırım	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Şirket yöneticileri 23 içeriden öğrenenler · 13 yöneticiler · 8 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Satışlar 12ay	Net 12ay
Zachary Roberts	President and CEO	01 Temmuz 2026 A	581.166	2	$-104.169
David D Chang	President and CEO	16 Mart 2026 S	5.150.599	2	$-289.459
Geoffrey M. Parker	CHIEF FINANCIAL OFFICER	02 Şubat 2026 A	1.252.795	2	$-88.539
Eric Thomas Schmidt	Chief Financial Officer	22 Mart 2023 A	862.439	0	$0
Earl Martin Douglas	SVP, General Counsel	21 Ağustos 2026 S	488.267	2	$-103.262
Annie Yoshiyama	SVP, Finance	21 Nisan 2026 S	124.517	2	$-29.311
Benjamin Machinas Beneski	SVP, Chief Technical Officer	31 Mart 2026 S	195.338	5	$-51.672
Timothy L. Moore	Chief Technical Officer	03 Şubat 2025 S	250.713	0	$0
Yinlin Jack Chen	SVP, Finance	10 Ağustos 2023 A	88.881	0	$0
Lillian Smith	VP, Corporate Counsel	01 Nisan 2023 A	140.390	0	$0
Alison Moore	Chief Technical Officer	22 Mart 2023 A	672.731	0	$0
Veer Bhavnagri	General Counsel	14 Mart 2023 F	556.049	0	$0
Rafael Amado	EVP of R&D	07 Ekim 2022 F	541.946	0	$0
Stephen Mayo	Yönetim kurulu üyesi	18 Haziran 2026 A	25.328	0	$0
Elizabeth A. Barrett	Yönetim kurulu üyesi	18 Haziran 2026 A	·	0	$0
Deborah M. Messemer	Yönetim kurulu üyesi	18 Haziran 2026 A	107.431	0	$0
Owen N. Witte	Yönetim kurulu üyesi	18 Haziran 2026 A	292.832	0	$0
Franz B Humer	Yönetim kurulu üyesi	18 Haziran 2026 A	307.507	0	$0
Joshua A Kazam	Yönetim kurulu üyesi	18 Haziran 2026 A	398.463	0	$0
Vicki L Sato	Yönetim kurulu üyesi	18 Haziran 2026 A	162.575	0	$0
PF Equity Holdings 2 B.V.	10% sahip	31 Mart 2022 J	0	0	$0
Pfizer Inc.	10% sahip	15 Ekim 2018 C	22.032.040	0	$0
Arie Belldegrun	·	02 Şubat 2026 A	2.236.816	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 22 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
BBC · ETFis Series Trust I	0,66%	163.586 NS	31 Temmuz 2026	N-PORT
LABU · Direxion Shares ETF Trust	0,16%	412.615 NS	31 Temmuz 2026	N-PORT
VFMO · VANGUARD WELLINGTON FUND	0,05%	496.849 SH	19 Ağustos 2026	Günlük
PWS · Pacer Funds Trust	0,04%	5.637 NS	31 Temmuz 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,04%	685.430 SH	01 Ekim 2026	Günlük
VTWV · VANGUARD SCOTTSDALE FUNDS	0,04%	231.043 SH	19 Ağustos 2026	Günlük
IBBQ · Invesco Exchange-Traded Fund Trust …	0,04%	24.445 SH	01 Ekim 2026	Günlük
IBB · iShares Trust	0,03%	1.977.547 SH	11 Eylül 2026	Günlük
VTWO · VANGUARD SCOTTSDALE FUNDS	0,02%	1.528.157 SH	19 Ağustos 2026	Günlük
OMFS · Invesco Exchange-Traded Self-Indexe…	0,02%	27.831 SH	01 Ekim 2026	Günlük
IWM · iShares Trust	0,02%	6.789.955 SH	11 Eylül 2026	Günlük
DFAS · Dimensional ETF Trust	0,01%	1.028.485 NS	31 Temmuz 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,01%	3.222.860 SH	19 Ağustos 2026	Günlük
VHT · VANGUARD WORLD FUND	0,01%	776.881 SH	19 Ağustos 2026	Günlük
DFAC · Dimensional ETF Trust	0,00%	241.276 NS	31 Temmuz 2026	N-PORT
ITOT · iShares Trust	0,00%	356.622 SH	11 Eylül 2026	Günlük
DFUS · Dimensional ETF Trust	0,00%	71.758 NS	31 Temmuz 2026	N-PORT
IWV · iShares Trust	0,00%	25.550 SH	03 Eylül 2026	Günlük
VTI · VANGUARD INDEX FUNDS	0,00%	8.666.591 SH	19 Ağustos 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	22.307 SH	19 Ağustos 2026	Günlük
IWN · iShares Trust	·	2.464.664 SH	11 Eylül 2026	Günlük
SMLF · iShares Trust	·	484.475 SH	11 Eylül 2026	Günlük

ALLO Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 18 analist AL

Medyan hedef $9.00 +500,0%

6 33,3% Güçlü Al

10 55,6% Al

2 11,1% Tut

0 0,0% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

9 analist · 2026-10-03

Ortalama hedef $9.00 +500,0%

← Tüm hedeflerin altında Mevcut fiyat $1.50

Düşük$4.00 Ortalama$9.00 Yüksek$14.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
ALLO	$314M	-1.6	-76.8%	·	-59.9%	·
SGMT	·	-3.7	·	·	-42.3%	·
CTMX	$725M	·	-44.8%	-22.8%	-15.9%	·
PRME	$626M	-2.6	55.3%	-4342.4%	-221.4%	·
ALT	$400M	-3.6	105.0%	-214861.0%	-45.6%	·
MPLT	$773M	-0.9	·	·	-151.1%	·
MNPR	·	·	·	·	·	·
CBIO	$327M	-24.2	-86.7%	-1419.6%	-90.0%	·
NGNE	$319M	-4.9	·	·	-33.6%	·
ZURA	·	·	·	·	·	·
CAPR	$1.66B	-12.8	-11.6%	·	-51.1%	·

Son Haberler Bu şirketten bahseden son manşetler

23

Allogene Therapeutics (ALLO): Yatırım Yapılacak En İyi 10 Adet 10 Dolar Altı Büyüme Hissesi Yahoo Finance · 5 ay, 1 hafta önce

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

ALLO Allogene Therapeutics, Inc. - Common Stock